Portfolio company
Amber Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an implantable adaptive neuromodulation system to treat women suffering from mixed urinary incontinence.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avation Medical
This company develops non-invasive wearable neuromodulation systems to treat patients suffering from overactive bladder and urinary incontinence.
Stimuli
This company develops a medical device using transcutaneous electrical nerve stimulation to treat adults suffering from overactive bladder symptoms and urinary urgency.
Audaxis Medical
The company develops polyurethane implants to treat stress urinary incontinence in women.
Axonics
This company develops and manufactures implantable sacral neuromodulation devices and hydrogel injections for adult patients suffering from urinary and bowel dysfunction.
Axena Health
This company develops a prescription medical device and app for women to treat urinary and faecal incontinence through at-home pelvic floor muscle training.
MYOPOWERS MEDICAL TECHNOLOGIES SA
This company develops implantable artificial muscle technology to restore muscle function for patients suffering from conditions such as stress urinary incontinence.
LiGalli
The company develops an intelligent intravaginal ring for controlled drug delivery and diagnostic monitoring for women with conditions such as overactive bladder.
Tesla Medical
This company develops non-invasive electroceutical devices using neural stimulation to treat patients suffering from chronic conditions such as an overactive bladder.